Associations between GV and 30-day mortality in the multiple regression model. by Shanshan Tang (363075)

Subjects:

The flowchart of patients’ selection. by Shanshan Tang (363075)

Subjects:

Dose-response relationship between the GV and 30-day mortality. by Shanshan Tang (363075)

Subjects:

Baseline characteristics of participants by GV quartiles. by Shanshan Tang (363075)

Subjects:

Kaplan-Meier survival curves for 30-day mortality. by Shanshan Tang (363075)

Subjects:

Associations between GV and ICU mortality in the multiple regression model. by Shanshan Tang (363075)

Subjects:

The growth of co-transformed cells in the peritoneal cavity alters viral gene expression to mirror that of PEL cell lines. by Mitchell Hayes (5334887)

The growth of co-transformed cells in the peritoneal cavity alters their cellular gene expression to mirror that of PEL biopsies. by Mitchell Hayes (5334887)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

Proportion of stillbirths in Stockholm among twin and singleton pregnancies. by Matilda Varli Hjärne (22766125)

Overexpression of miR-184 disrupts pleated septate junctions in peripheral nerves. by Sravya Paluri (5475260)

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …”

Key safety measures including adverse events. by Anuja Dokras (8679261)

“…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m²; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …”